id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0446-0016,FDA,FDA-2013-D-0446,Expanded Access to Investigational Drugs for Treatment Use; Questions and Answers; Guidance for Industry; Revised Draft Guidance,Other,Guidance,2022-11-04T04:00:00Z,2022,11,2022-11-04T04:00:00Z,2023-01-04T04:59:59Z,2024-11-12T23:46:50Z,,1,0,090000648547b9f2
FDA-2013-D-0446-0015,FDA,FDA-2013-D-0446,Expanded Access to Investigational Drugs for Treatment Use: Questions and Answers; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2022-11-02T04:00:00Z,2022,11,,,2022-11-02T13:00:13Z,2022-23785,0,0,090000648547b466